Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandeep Menon currently holds 441,350 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Chief R&D Officer.
Based on SEC Form 4 filings, Sandeep Menon has been a net neutral trader of BCRX stock. They have purchased $0 and sold $0 worth of shares.
Sandeep Menon's most recent insider trade was on Apr 6, 2026, when they sold 441,350 shares at $0.00 per share.
Sandeep Menon serves as Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Sandeep Menon holds the position of Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Sandeep Menon has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sandeep Menon was on Apr 6, 2026, when they purchased $0 worth of BCRX shares. This transaction involved 441,350 shares at N/A per share.
Sandeep Menon currently owns 441,350 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandeep Menon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandeep Menon has 2 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Sandeep Menon and 40,000+ other insiders.